Abstract:Background: Impaired functional connectivity between the bilateral hemispheres may serve as the neural substrate for anxiety and depressive disorders, yet its role in comorbid generalized anxiety disorder (GAD) and depression, as well as the effect of treatment on this connectivity, remains unclear. We sought to examine functional connectivity between homotopic regions of the 2 hemispheres (voxel-mirrored homotopic connectivity [VMHC]) among people with GAD with and without comorbid depression at baseline and after a 4-week paroxetine treatment. Methods: Drug-naïve patients with GAD, with or without comorbid depression and healthy controls underwent functional magnetic resonance imaging and clinical assessments at baseline and after treatment. We compared VMHC and seed-based functional connectivity across the 3 groups. We performed correlation analysis and support vector regression (SVR) to examine the intrinsic relationships between VMHC and symptoms. Results: Both patient groups (n = 40 with GAD only, n = 58 with GAD and depression) showed decreased VMHC in the precuneus, posterior cingulate cortex and lingual gyrus compared with healthy controls (n = 54). Moreover, they showed decreased VMHC in different brain regions compared with healthy controls. However, we did not observe any significant differences between the 2 patient groups. Seeds from abnormal VMHC clusters in patient groups had decreased functional connectivity. Voxel-mirrored homotopic connectivity in the precuneus, posterior cingulate cortex and lingual gyrus was negatively correlated with cognitive impairment among patients with GAD only and among all patients. The SVR analysis based on abnormal VMHC showed significant positive correlations (p < 0.0001) between predicted and actual treatment responses. However, we did not observe significant differences in VMHC or functional connectivity after treatment. Limitations: A notable dropout rate and intergroup somatic symptom variations may have biased the results. Conclusion: Patients with GAD with or without comorbid depression exhibited shared and distinct abnormal VMHC patterns, which might be linked to their cognitive deficits. These patterns have the potential to serve as prognostic biomarkers for GAD.Clinical trial registration: ClinicalTrials.gov NCT03894085.

Brain structural abnormalities in patients with major depression with or without generalized anxiety disorder comorbidity

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder

Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study.

Abnormal Multi-Layered Dynamic Cortico-Subcortical Functional Connectivity in Major Depressive Disorder and Generalized Anxiety Disorder.

Disrupted functional connectivity associated with cognitive impairment in generalized anxiety disorder (GAD) and comorbid GAD and depression: a follow-up fMRI study

Cortical Thickness and White Matter Integrity Abnormalities in Obsessive-Compulsive Disorder: A Combined Multimodal Surface-Based Morphometry and Tract-Based Spatial Statistics Study

Alterations in white matter volume and its correlation with clinical characteristics in patients with generalized anxiety disorder

Common and Specific Abnormalities in Cortical Thickness in Patients with Major Depressive and Bipolar Disorders

Alternations in Cortical Thickness and Functional Connectivity in Patients with Generalized Anxiety Disorder

Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms.

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder

Gray Matter Volume Abnormalities in Depressive Patients with and Without Anxiety Disorders.

Aberrant Gray Matter Networks in Non-comorbid Medication-Naive Patients With Major Depressive Disorder and Those With Social Anxiety Disorder.

The difference in volumetric alternations of the orbitofrontal-limbic-striatal system between major depressive disorder and anxiety disorders: A systematic review and voxel-based meta-analysis

The Dark and Gloomy Brain: Grey Matter Volume Alterations in Major Depressive Disorder–Fine-Grained Meta-Analyses

Sex-specific alterations of cortical morphometry in treatment-naïve patients with major depressive disorder

Aberrant Inter-hemispheric Connectivity in Patients With Recurrent Major Depressive Disorder: A Multimodal MRI Study

Decreased Cortical Folding of the Fusiform Gyrus and Its Hypoconnectivity with Sensorimotor Areas in Major Depressive Disorder

Neurobiological Commonalities and Distinctions among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.